Currently, Romania ranks first in Europe with regard to cervicalcancer mortality.
2
Objective: Molecular and environmental co-factors are known risk factors for cervicalcancer.
3
However, its effects and mechanism of a-mangostin in cervicalcancer remain unclear.
4
However, the diagnostic molecules for early cervicalcancer are not very clear.
5
However, its biological function and molecular mechanisms in cervicalcancer remain unclear.
1
Conclusions: Clinical activity of a veliparib-topotecan combination was minimal in women with persistent or recurrent uterinecervixcancer.
2
CDP is considered a promising method for screening the uterinecervixcancer and its precursor lesions in developing countries.
1
The ASR of cervixutericancer in women was 1.78.
Uso de cervix cancer en inglés
1
The number of cases describing this neurologic complication in cervixcancer is increasing.
2
Currently, control of cervixcancer is through early detection and treatment.
3
These results provide evidence that HPV73 is an oncogenic virus that can cause invasive cervixcancer.
4
Integration of HPV73 sequences into the cancer cell genomes was identified in all cervixcancer tissues.
5
The inhibitors decreased the proliferation of cervixcancer cells, while growth of primary normal keratinocytes was not affected.
6
Conclusions: Clinical activity of a veliparib-topotecan combination was minimal in women with persistent or recurrent uterine cervixcancer.
7
CDP is considered a promising method for screening the uterine cervixcancer and its precursor lesions in developing countries.
8
Patients and methods: We report a case of leptomeningeal carcinomatosis secondary to endometrial carcinoma and 2 complex cervixcancer cases.
9
We recently reported that VHR is upregulated in several cervixcancer cell lines as well as in carcinomas of the uterine cervix.
10
Objectives: This study aims to investigate the efficacy of screening by low-cost technology in down-staging and reducing mortality due to breast and cervixcancer.
11
Screening programs (especially for cervixcancer), and more available and better facilities for cancer therapy, may have helped to reduce mortality for several cancers.
12
Results: The average compliance is 71.43 and 64.93% for breast and cervixcancer screening, respectively, with the highest compliance in round 1.
13
Methods: A database consisting of over 5000 patients with stage IB-IIIB cervixcancer treated between 1963 and 1992 revealed 35 patients with sigmoid perforation.
14
At the end of 3 screening rounds, 94 and 84% of the eligible women were screened at least once for breast and cervixcancer, respectively.
15
With current molecular screening and HPV vaccination, not all cervixcancers will be prevented.